Papers

Research literature with structured metadata.

Trials

Registered studies by status, phase, and compound.

Topics

Indications and themes psychedelics are researched for.

Compounds

Evidence across molecules with rich data.

Countries

Regulation, access, and research activity by region.

Stakeholders

Organizations shaping the space across research, policy, and funding.

People

Investigators, clinicians, and authors with mapped output.

Courses

Training programs and certifications across modalities.

Events

Conferences, workshops, and convenings by date and focus.

Research recaps

Monthly evidence summaries with key takeaways.

Map of research

Landscape view of trials, compounds, and outcomes.

Newsletter

Weekly or daily updates on trials, publications, analysis, and more.

Research Groups

Worldwide map of psychedelic research centres by region.

Research Network

Interactive co-authorship map of psychedelic researchers.

Top papers

Find needles in the haystack of psychedelic research per topic.

Pricing
Back to Stakeholders
Specialized Academic Departments and InstitutesIndependent Academic Research Groups

University of New Mexico

United States
6 Trials

Pioneer in modern American psychedelic research through Rick Strassman's DMT and psilocybin studies in the 1990s — among the first human psychedelic research since the 1970s. Today, UNM Health Sciences conducts active trials of psilocybin, MDMA, and ketamine for depression, PTSD, alcohol use disorder, and methamphetamine addiction.

Quick Facts

Type
Other
HQ
United States
Website
Visit

Sponsored Trials

5
RecruitingII

MDMA for Co-occurring PTSD and OUD After Childbirth

Start Date
March 1, 2024
Compounds
MDMA
WithdrawnI, II

Connectivity Changes Associated With Ketamine Assisted Psychotherapy for PTSD

Start Date
December 31, 2023
Compounds
Ketamine
CompletedI

EEG Characteristics in ECT

Start Date
October 1, 2019
Compounds
Placebo, Ketamine
CompletedI

Spreading Depolarization and Ketamine Suppression

Start Date
January 7, 2015
Compounds
Ketamine
CompletedII

Effects and Therapeutic Potential of Psilocybin in Alcohol Dependence

Start Date
January 1, 2012
Compounds
Psilocybin

Collaborated Trials

1
CompletedII

A Double-Blind Trial of Psilocybin-Assisted Treatment of Alcohol Dependence

Start Date
June 1, 2014
Compounds
Psilocybin, Placebo

The intelligence layer for psychedelic research.

Company

  • About
  • Contact
  • Newsletter

Product

  • Feedback
  • Roadmap
  • Changelog
  • API

Legal

  • Privacy
  • Terms

© 2026 Blossom. All rights reserved.